SAFETY WARNING Food supplements are not intended to replace a varied and balanced diet
Ozempic, Mounjaro, Wegovy, Zepbound, Saxenda, and Foundayo are in a newer class of drugs called GLP-1 agonists
People who've gone on these new medications, generically called semaglutide, do tend to lose a considerable amount of weight
Tens of thousands of reports of health problems after taking Ozempic have been filed with the FDA Adverse Event Reporting System
These typically lessen with continued use and dosage adjustments
Related Key Terms: Glucagon-Like Peptide-1, GLP-1, metabolic diseases, metabolism, proglucagon, insulin, diabetes Specifications Kit Contents Product Details Documentation Order Details K1516LK Customer Service/Orders Technical Support Company Headquarters